Alnylam Pharmaceuticals, Inc. (ALNY)
336.19
-3.18
(-0.94%)
USD |
NASDAQ |
Feb 20, 16:00
337.00
+0.81
(+0.24%)
After-Hours: 20:00
Alnylam Pharmaceuticals EPS Diluted (TTM) : 2.257 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Insmed, Inc. | -6.403 |
| Biogen, Inc. | 8.806 |
| Pfizer Inc. | 1.355 |
| Eli Lilly & Co. | 22.59 |
| AbbVie, Inc. | 2.361 |